Fundraising Fox
Exelixis
NASDAQ: EXELSan Francisco Bay Area, US · Founded 1994 · 1,588 employees on LinkedIn · 1 known investors
Find your way into Exelixis
Sign up to see every warm intro you have to Exelixis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Exelixis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Exelixis is an oncology company that discovers and develops cancer treatments, including small molecule therapeutics and biotherapeutics such as antibody-drug conjugates, for patients across multiple tumor types. Its flagship commercial product is CABOMETYX (cabozantinib), and it operates through global development and commercialization partnerships.
Founders & leadership
Investors · 1
Founder mafia
The Exelixis mafia →13 people who came through Exelixis went on to found or lead other companies.
Richard HeymanSr. Vice PresidentFounded Aragon Pharmaceuticals +3Angie YouDirector, Business DevelopmentFounded Amunix Pharmaceuticals +1Marc Tessier-LavigneMember, Scientific Advisory BoardFounded Denali Therapeutics +1Harrison YoonScientist IIFounded Cacultured +1Jen HerbachDirector of MarketingFounded Adventris PharmaceuticalsMark Taegon BaikSenior ScientistFounded Arum TherapeuticsSang Hoon LeeSenior Scientist IIFounded ABL Bio Venture CapitalSteven JamesSVP Commercial OperationsFounded Pionyr ImmunotherapeuticsBen BurleyResearch ScientistFounded VistaPath BiosystemsSamuel LevyResearch AssociateFounded ClearNote HealthKristine BallVP FinanceFounded Antiva BiosciencesGeoffrey DuykPresident of R&DFounded Grove Biopharma
Related companies · 3
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
ADPADP provides cloud-based human capital management solutions that integrate payroll, HR, talent management, time and attendance, tax, and benefits administration for businesses globally. The company serves as a comprehensive provider of HCM software and business outsourcing services with analytics and compliance expertise.
Eli LillyEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
Companies working in the same space as Exelixis.
Frequently asked questions
- What does Exelixis do?
- Exelixis is an oncology company that discovers and develops cancer treatments, including small molecule therapeutics and biotherapeutics such as antibody-drug conjugates, for patients across multiple tumor types. Its flagship commercial product is CABOMETYX (cabozantinib), and it operates through global development and commercialization partnerships.
- Who are Exelixis's investors?
- Exelixis's investors include Atlas Venture.
- Where is Exelixis headquartered?
- Exelixis is headquartered in San Francisco Bay Area, US.